# Heart–gut interaction in veno-arterial extracorporeal membrane oxygenation: a forgotten axis in critical care perfusion

**Authors:** Amr Omar

PMC · DOI: 10.1007/s10047-025-01543-6 · Journal of Artificial Organs · 2026-01-05

## TL;DR

This editorial highlights the importance of protecting the gut during VA-ECMO treatment to prevent organ failure and improve patient outcomes.

## Contribution

The paper emphasizes the heart-gut axis as a critical but often overlooked aspect of VA-ECMO management.

## Key findings

- VA-ECMO can cause gut injury through microcirculatory dysfunction and ischemia-reperfusion.
- Gut dysfunction during VA-ECMO leads to bacterial translocation and systemic inflammation.
- Incorporating gut-protective strategies in VA-ECMO protocols is essential for better outcomes.

## Abstract

The expanding use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock and post-cardiotomy support necessitates a focus on perfusion beyond traditional targets. The gastrointestinal tract (GIT) is particularly vulnerable, yet its dysfunction is often overlooked in ECMO management. This editorial synthesizes current literature and pathophysiological principles to analyze the mechanisms of GIT injury during VA-ECMO support. We examine the impact of VA-ECMO on hemodynamics, microcirculation, and inflammation, with a focus on the heart-gut axis. VA-ECMO compromises gut integrity through multiple interconnected pathways. These include microcirculatory dysfunction due to non-pulsatile flow and vasopressor use, increased left ventricular afterload, and ischemia-reperfusion injury. The phenomenon of “dual circulation” in peripheral VA-ECMO creates a risk of heterogeneous oxygen delivery, potentially leaving the GIT hypoperfused. These insults lead to mucosal barrier failure, bacterial translocation, and systemic inflammation, driving sequential organ failure. Early recognition of gut dysfunction, through clinical monitoring and biomarkers, is challenging but critical. Given the high morbidity and mortality associated with VA-ECMO, the GIT must be acknowledged as a critical target organ. A paradigm shift integrating gut-protective strategies, such as meticulous fluid management, enteral nutrition, and monitoring for signs of hypoperfusion into standard VA-ECMO protocols is essential to improve patient outcomes.

## Linked entities

- **Diseases:** cardiogenic shock (MONDO:0800175)

## Full-text entities

- **Genes:** Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 114105] {aka Mip-2, Scyb2}, FABP2 (fatty acid binding protein 2) [NCBI Gene 2169] {aka FABPI, I-FABP}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Angpt2 (angiopoietin 2) [NCBI Gene 89805] {aka Agpt2, Ang-2}, Vwf (von Willebrand factor) [NCBI Gene 116669], Icam1 (intercellular adhesion molecule 1) [NCBI Gene 25464] {aka CD54, ICAM, RICAM-I}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** bacterial (MESH:D001424), anemia (MESH:D000740), mucosal injury (MESH:D052016), Abdominal distension (MESH:D000007), CS (MESH:D012770), tissue injury (MESH:D017695), ischemic (MESH:D002545), GI bleeding (MESH:D006470), UGIB (MESH:D006471), multiorgan dysfunction (MESH:D009102), gastroduodenal ulcers (MESH:D010437), ulcerative lesions (MESH:D014456), edema (MESH:D004487), gut dysfunction (MESH:C535334), GI injury (MESH:D014947), ischemia (MESH:D007511), intestinal injury (MESH:D007410), Altered bowel sounds (MESH:D012135), Gastrointestinal dysfunction (MESH:D005767), Inflammatory (MESH:D007249), septic shock (MESH:D012772), pulmonary inflammation (MESH:D011014), GIT (MESH:D005770), Venous congestion (MESH:D006940), Ischemia-Reperfusion Injury (MESH:D015427), microvascular disturbances (MESH:D017566), endothelial damage (MESH:D014652)
- **Chemicals:** lactate (MESH:D019344), ECPR (-), oxygen (MESH:D010100), bilirubin (MESH:D001663)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12769693/full.md

---
Source: https://tomesphere.com/paper/PMC12769693